We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics
Gold Supplier
Nucleic Acid Extraction System
Next-Generation Sequencing Platform
Clear Dx
Gold Supplier
Rapid PCR Diagnostic System
Accula System
Laboratory Management Software
Visit expo >

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
23 Sep 2021 - 25 Sep 2021


Image: The QX200 Droplet Digital PCR system (Photo courtesy of Bio-Rad).

ctDNA Provides Prognostic Clues in Advanced BRAF-Mutated Melanoma Cases

A BRAF mutation is a change in a BRAF gene. That change in the gene can lead to an alteration in a protein that regulates cell growth that could allow the melanoma to grow more aggressively. Approximately half of melanomas carry this mutation and are referred to as mutated, or BRAF positive. More...
02 Mar 2021
Image: High-power photomicrograph of ductal adenocarcinoma (Prostate cancer) illustrating tall columnar cells with pale to clear cytoplasm and large ovoid nuclei (Photo courtesy of David J. Grignon, MD).

22-Gene Genomic Classifier Validated in Recurrent Prostate Cancer Patients

When prostate cancer has been detected or has returned following initial treatment with surgery, radiation therapy and/or hormone therapy, it is said to be recurrent or relapsed. Treatment of recurrent prostate cancer depends on what treatment a patient has previously received and the extent of the cancer. More...
25 Feb 2021
Image: The Simoa HD-1 Analyzer is a novel fully automated digital immunoassay analyzer with single-molecule sensitivity and multiplexing (Photo courtesy of Quanterix).

Blood Biomarker Predicts Dementia in Cerebral Small Vessel Disease

Cerebral small vessel disease (SVD) is a highly prevalent condition, which causes lacunar stroke, vascular cognitive impairment and vascular dementia. Few treatments have been shown to delay disease progression. More...
24 Feb 2021
Image: Glioblastoma omics highlights informative tumor features, immune subtypes (Photo courtesy of Washington University in St. Louis).

Proteogenomic And Metabolomic Studies Characterize Human Glioblastoma

Glioblastoma (GBM) is an aggressive type of cancer that can occur in the brain or spinal cord. Glioblastoma forms from cells called astrocytes that support nerve cells. Glioblastoma can occur at any age, but tends to occur more often in older adults. It can cause worsening headaches, nausea, vomiting and seizures. More...
23 Feb 2021
Image: Exome sequencing workflow: Double-stranded genomic DNA is fragmented by sonication. Linkers are then attached to the DNA fragments, which are then hybridized to a capture microarray designed to target only the exons (Photo courtesy of SarahKusala).

Exome Sequencing Identified Pathogenic Variants in Cerebral Palsy Patients

Cerebral palsy (CP) is a group of permanent movement disorders that appear in early childhood. Signs and symptoms vary among people and over time. Often, symptoms include poor coordination, stiff muscles, weak muscles, and tremors. More...
18 Feb 2021
Image: Histopathology of drug-induced acute interstitial nephritis showing interstitial inflammation with prominent eosinophils and tubulitis (the presence of inflammatory cells within the tubular wall) (Photo courtesy of NephSim).

Biomarkers Evaluate Kidney Injury in Cancer Patients

Immune checkpoint inhibitors (ICI) are monoclonal antibodies that can unleash the immune system by blocking surface molecules that serve as important breaks (or checkpoints) that mediate negative regulation of T cells. ICI have substantially improved the prognosis for patients with a wide range of malignancies. More...
17 Feb 2021
Image: The Z2 Coulter Counter Analyzer can be used to analyze virtually any cell type and species variation (Photo courtesy of Beckman Coulter).

Biomarker Predicts Pancreatic Cancer Patients’ Response to CD40 Immunotherapy

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and currently the third leading cause of cancer deaths in the USA. Despite the fact that it only accounts for about 3% of new cancer cases, it is responsible for more than 7% of all cancer deaths, and only10% of patients survive five years with the disease. More...
17 Feb 2021

The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
Copyright © 2000-2021 Globetech Media. All rights reserved.